Close Menu
Home » Myriad Pushes for Payor Coverage Based on GeneSight RCT Data

Myriad Pushes for Payor Coverage Based on GeneSight RCT Data

May 10, 2018
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) – Myriad Genetics presented new data this week on the impact of its GeneSight pharmacogenomic test in the care of patients with moderate to severe depression, and expressed confidence that the data, alongside other clinical impact and health economic evidence, will help it broaden payor coverage for the test.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Gene Editing for the Gold

Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.

Variant Linked to Heart Failure Risk

A genetic alteration appears to increase heart failure risk among people of African descent, according to the Washington Post.

A Different Future

In his look back at the past decade, BuzzFeed News' Peter Aldhous writes that direct-to-consumer genetic testing has led to "Facebook for genes."

Nature Examines Lifespans, Fast and Accurate Method for Long-Read Assembly, More

In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

  2. Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

    Premium

  3. ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

  4. At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

  5. GenMark Diagnostics Downgraded by JP Morgan to Neutral

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.